UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis

European journal of immunology, 2001-10, Vol.31 (10), p.2910-2918

2001

Volltextzugriff (PDF)

Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles

Cellular immunology, 2003-09, Vol.225 (1), p.12-20

2003

Volltextzugriff (PDF)

Cardiac Safety Profile of Nebulized Formoterol in Adults with COPD: A 12-Week, Multicenter, Randomized, Double- Blind, Double-Dummy, Placebo- and Active-Controlled Trial

Clinical therapeutics, 2007-10, Vol.29 (10), p.2167-2178

2007

Volltextzugriff (PDF)

Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-Hodgkin lymphoma

Journal of immunotherapy, 2007-01, Vol.30 (1), p.64-74

2007

Volltextzugriff (PDF)

Long-term safety of nebulized formoterol: Results of a twelve-month open-label clinical trial

Therapeutic advances in respiratory disease, 2008-08, Vol.2 (4), p.199-208

2008

Volltextzugriff (PDF)

Analysis of immunization with DNA encoding Pseudomonas aeruginosa exotoxin A

FEMS immunology and medical microbiology, 2000-02, Vol.27 (2), p.147-154

2000

Volltextzugriff (PDF)

Phase I studies of interleukin (IL)-2 and rituximab in B-cell non-Hodgkin's lymphoma: IL-2 mediated natural killer cell Expansion correlations with clinical response

Clinical cancer research, 2004-04, Vol.10 (7), p.2253-2264

2004

Volltextzugriff (PDF)

Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice

The Journal of immunology (1950), 2000-09, Vol.165 (5), p.2850-2858

2000

Volltextzugriff (PDF)

Phase I Studies of Interleukin (IL)-2 and Rituximab in B-Cell Non-Hodgkin’s Lymphoma

Clinical cancer research, 2004-04, Vol.10 (7), p.2253-2264

2004

Volltextzugriff (PDF)

Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: A placebo-controlled trial

Respiratory medicine, 2008-04, Vol.102 (4), p.479-487

2008

Volltextzugriff (PDF)

Efficacy and Safety of Nebulized Formoterol as Add-on Therapy in COPD Patients Receiving Maintenance Tiotropium Bromide: Results from a 6-Week, Randomized, Placebo-Controlled, Clinical Trial

Drugs (New York, N.Y.), 2009-06, Vol.69 (9), p.1205-1216

2009

Volltextzugriff (PDF)

Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients

Respiratory medicine, 2008-02, Vol.102 (2), p.189-197

2008

Volltextzugriff (PDF)

IN COPD, NEBULIZED FORMOTEROL FUMARATE PROVIDES PROLONGED BRONCHODILATION AND INCREASED PATIENT SATISFACTION COMPARED TO ALBUTEROL/IPRATROPIUM MDI

Chest, 2008-10, Vol.134 (4), p.107

2008

Volltextzugriff (PDF)

Nebulized formoterol effect on bronchodilation and satisfaction in COPD patients compared to QID ipratropium/albuterol MDI

Current medical research and opinion, 2009-03, Vol.25 (3), p.653-661

2009

Volltextzugriff (PDF)

SAFETY AND EFFICACY OF CONCOMITANT TREATMENT WITH NEBULIZED FORMOTEROL AND TIOTROPIUM IN COPD

Chest, 2007-10, Vol.132 (4), p.531B-531B

2007

Volltextzugriff (PDF)

CARDIOVASCULAR SAFETY OF NEBULIZED FORMOTEROL IN COPD PATIENTS: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Chest, 2007-10, Vol.132 (4), p.529B-529B

2007

Volltextzugriff (PDF)

Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease

Advances in therapy, 2009-11, Vol.26 (11), p.1024-1034

2009

Volltextzugriff (PDF)

LONG-TERM SAFETY OF NEBULIZED FORMOTEROL IN COPD: AN OPEN-LABEL ACTIVE-CONTROLLED EXTENSION STUDY

Chest, 2007-10, Vol.132 (4), p.531A-531A

2007

Volltextzugriff (PDF)

Nebulized formoterol fumarate: Dose selection and pharmacokinetics

Pulmonary pharmacology & therapeutics, 2008-10, Vol.21 (5), p.818-823

2008

Volltextzugriff (PDF)

Pseudomonas Exotoxin-Mediated Delivery of Exogenous Antigens to MHC Class I and Class II Processing Pathways

Cellular immunology, 2000-08, Vol.203 (2), p.75-83

2000

Volltextzugriff (PDF)

Analysis of immunization with DNA encoding Pseudomonas aeruginosa exotoxin A

FEMS immunology and medical microbiology, 2000-02, Vol.27 (2), p.147-154

2000

Volltextzugriff (PDF)

Detection of human enteric viruses in stream water with RT-PCR and cell culture

Journal of water and health, 2004-03, Vol.2 (1), p.37-47

2004

Volltextzugriff (PDF)

Studies on the presentation of pseudomonas exotoxin to the host immune system: Implications for vaccine development

Denis-Mize, Kimberly S

1998

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)
Dissertationen
(1)

Sprache

Englisch
(23)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Female
(13)
Humans
(13)
Male
(10)
Middle Aged
(9)
Formoterol Fumarate
(8)
Pulmonary Disease, Chronic Obstructive - Drug Therapy
(8)
Biological And Medical Sciences
(7)
Immunology
(7)
Aged
(6)
Animals
(6)
Double-Blind Method
(6)
Ethanolamines - Administration & Dosage
(6)
Formoterol
(6)
Medical Sciences
(6)
Mice
(6)
Administration, Inhalation
(5)
Bronchodilator Agents - Administration & Dosage
(5)
Copd
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis

Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles

Cardiac Safety Profile of Nebulized Formoterol in Adults with COPD: A 12-Week, Multicenter, Randomized, Double- Blind, Double-Dummy, Placebo- and Active-Controlled Trial

Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-Hodgkin lymphoma

Long-term safety of nebulized formoterol: Results of a twelve-month open-label clinical trial

Analysis of immunization with DNA encoding Pseudomonas aeruginosa exotoxin A

Phase I studies of interleukin (IL)-2 and rituximab in B-cell non-Hodgkin's lymphoma: IL-2 mediated natural killer cell Expansion correlations with clinical response

Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice

Phase I Studies of Interleukin (IL)-2 and Rituximab in B-Cell Non-Hodgkin’s Lymphoma

Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: A placebo-controlled trial

Efficacy and Safety of Nebulized Formoterol as Add-on Therapy in COPD Patients Receiving Maintenance Tiotropium Bromide: Results from a 6-Week, Randomized, Placebo-Controlled, Clinical Trial

Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients

IN COPD, NEBULIZED FORMOTEROL FUMARATE PROVIDES PROLONGED BRONCHODILATION AND INCREASED PATIENT SATISFACTION COMPARED TO ALBUTEROL/IPRATROPIUM MDI

Nebulized formoterol effect on bronchodilation and satisfaction in COPD patients compared to QID ipratropium/albuterol MDI

SAFETY AND EFFICACY OF CONCOMITANT TREATMENT WITH NEBULIZED FORMOTEROL AND TIOTROPIUM IN COPD

CARDIOVASCULAR SAFETY OF NEBULIZED FORMOTEROL IN COPD PATIENTS: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease

LONG-TERM SAFETY OF NEBULIZED FORMOTEROL IN COPD: AN OPEN-LABEL ACTIVE-CONTROLLED EXTENSION STUDY

Nebulized formoterol fumarate: Dose selection and pharmacokinetics

Pseudomonas Exotoxin-Mediated Delivery of Exogenous Antigens to MHC Class I and Class II Processing Pathways

Analysis of immunization with DNA encoding Pseudomonas aeruginosa exotoxin A

Detection of human enteric viruses in stream water with RT-PCR and cell culture

Studies on the presentation of pseudomonas exotoxin to the host immune system: Implications for vaccine development

Suchergebnisse filtern